DENIM ERVIN: Open Payments
NPI 1679789291 · PARIS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$990 in 42 payments from 24 companies in 2025. Trend: 2023 $777 · 2024 $598 · 2025 $990
Food & beverage: $891Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $237 |
| Gilead Sciences, Inc. | 3 | $70 |
| Merck Sharp & Dohme LLC | 3 | $69 |
| E.R. Squibb & Sons, L.L.C. | 3 | $62 |
| Novartis Pharmaceuticals Corporation | 2 | $49 |
| Astellas Pharma US Inc | 2 | $44 |
| Janssen Biotech, Inc. | 2 | $42 |
| PFIZER INC. | 2 | $42 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| Lilly USA, LLC | 2 | $34 |
Products named: IMBRUVICA, Trodelvy, KEYTRUDA, EPKINLY, KISQALI, RYBREVANT, Xtandi, OPDIVO.
Industry payments across TX — which companies pay providers there.
